Creso Pharma hits Europe with cannabis pill

Company News

by Rachael Jones

Creso Pharma (ASX:CPH) is set to release CBD-based pills and supplements for sports pain relief across Europe.

They are addressing the need for organic and efficient support for the management of pain - related to sports injuries and age-related symptoms such as stiffness from arthritis.

They have partnered with the largest independent Swiss manufacturing group called FRIKE technologies to produce the CBD-based range.

The company will introduce the cannaDOL product across Europe to alleviate joint and muscle pain.

Shares in Creso Pharma (ASX:CPH) are currently trading around 2.96 per cent higher to $0.87.

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.